# Rivaroxaban Combined With DAPT Versus DAPT Alone After Drug-coated Balloon Angioplasty

> **NCT05750758** · NA · COMPLETED · sponsor: **Henan Institute of Cardiovascular Epidemiology** · enrollment: 140 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** rivaroxaban

## Key facts

- **NCT ID:** NCT05750758
- **Lead sponsor:** Henan Institute of Cardiovascular Epidemiology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-20
- **Primary completion:** 2023-08-10
- **Final completion:** 2023-12-01
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2024-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05750758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05750758, "Rivaroxaban Combined With DAPT Versus DAPT Alone After Drug-coated Balloon Angioplasty". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05750758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*